Title:
モルホリノキナゾリン系化合物の結晶形の結晶、その製造方法、使用および医薬品組成物
Document Type and Number:
Japanese Patent JP7071588
Kind Code:
B2
Abstract:
A crystal form I of a morpholino quinazoline compound represented by the following formula A, a preparation method therefor and use thereof. The crystal form I has good stability and non-hygroscopicity, and the preparation method is simple and suitable for industrial production.
Inventors:
Shu Zushen
Lou Yangton
Lou Yangton
Application Number:
JP2021516990A
Publication Date:
May 19, 2022
Filing Date:
September 12, 2019
Export Citation:
Assignee:
Shanghai Inley Pharmaceutical Company Limited
International Classes:
C07D401/14; A61K31/5377; A61P1/04; A61P3/00; A61P5/00; A61P9/00; A61P11/06; A61P17/06; A61P17/08; A61P19/02; A61P25/00; A61P29/00; A61P31/12; A61P35/00; A61P37/00; A61P37/08; A61P43/00
Domestic Patent References:
| JP2016533372A | ||||
| JP2017519021A |
Other References:
BAVIN, Mike,Polymorphism in process development,Chemistry & Industry,1989年,Vol.21,pp.527-529
BYRN, S. et al.,Pharmaceutical solids: A strategic approach to regulatory considerations,Pharmaceutical Research,1995年,Vol.12, No.7,pp.945-954
森部久仁一 ほか,非晶質医薬品の調製と評価,低温生物工学会誌,2005年,Vol.51, No.1,pp.19-24
GOEL, R. K. et al.,Quinazolines revisited: search for novel anxiolytic and GABA ergic agents,Bioorganic & Medicinal Chemistry Letters,2005年,Vol.15, No.8,pp.2145-2148
BYRN, S. et al.,Pharmaceutical solids: A strategic approach to regulatory considerations,Pharmaceutical Research,1995年,Vol.12, No.7,pp.945-954
森部久仁一 ほか,非晶質医薬品の調製と評価,低温生物工学会誌,2005年,Vol.51, No.1,pp.19-24
GOEL, R. K. et al.,Quinazolines revisited: search for novel anxiolytic and GABA ergic agents,Bioorganic & Medicinal Chemistry Letters,2005年,Vol.15, No.8,pp.2145-2148
Attorney, Agent or Firm:
Fujiharu
Miki Kawakami
Rie Kawai
Miki Kawakami
Rie Kawai
Previous Patent: Battery module and battery pack containing the battery module
Next Patent: System fittings with casement windows
Next Patent: System fittings with casement windows